Proton Therapy for Chordomas and/or Chondrosarcomas (CH01)
The purpose of this study is to collect information from medical records to see what effects proton beam radiation has on cancer and analyze possible side effects.
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||A Clinical Outcomes Protocol of Proton Beam Radiation Therapy for Chordomas and/or Chondrosarcomas of the Base of Skull and/or Spine|
- Collect and analyze outcome data on tumor control. [ Time Frame: When each patient has been followed for a minimum of 12 month and then again after 24 months to a maximum of 10 years. ] [ Designated as safety issue: No ]
- Collect and analyze data on normal tissue morbidity. [ Time Frame: When each patient has been followed for a minimum of 12 months and then again after 24 months to a maximum of 10 years. ] [ Designated as safety issue: Yes ]Specifically analyzing pituitary, visual and hearing function.
|Study Start Date:||January 2007|
|Estimated Study Completion Date:||January 2022|
|Estimated Primary Completion Date:||January 2022 (Final data collection date for primary outcome measure)|
Data collection will be obtained from the patient's medical records including initial evaluation, pathology report, dosimetry information, radiotherapy completion records and follow-up.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00797602
|Contact: Intake Coordinator||877-686-6009|
|United States, Florida|
|University of Florida Proton Therapy Institute||Recruiting|
|Jacksonville, Florida, United States, 32206|
|Contact: Intake Coordinator 877-686-6009|
|Principal Investigator: Ronny L Rotondo, MD, CM, FRCPC|
|Principal Investigator:||Ronny L Rotondo, MD, CM, FRCPC||University of Florida Proton Therapy Institute|